Showing results (71-80 of 102) with videos related to
Sort By:
Pageof 11
Stroke|February 27, 2020
Dabigatran Treatment of Acute Noncardioembolic Ischemic StrokeKen S Butcher, Kelvin Ng, Patrick Sheridan, et al.AJNR. American Journal of Neuroradiology|August 1, 2025
Tenecteplase versus Alteplase and First-Pass Reperfusion in Endovascular ThrombectomyWilliam K Diprose, Fouzi Bala, Bijoy K Menon, et al.AJNR. American Journal of Neuroradiology|April 25, 2026
Age-adjustment of the combined early ischemic change and collateral extent score for outcomes after endovascular therapyKoji Tanaka, Aravind Ganesh, Jianhai Zhang, et al.International Journal of Stroke : Official Journal of the International Stroke Society|April 27, 2024
A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trialNishita Singh, Carol C Kenney, Ken S Butcher, et al.Stroke|July 8, 2021
Comparing the Prognostic Impact of Age and Baseline National Institutes of Health Stroke Scale in Acute Stroke due to Large Vessel OcclusionJohanna Maria Ospel, Scott Brown, Manon Kappelhof, et al.Radiology|June 1, 2021
Radiologic Patterns of Intracranial Hemorrhage and Clinical Outcome after Endovascular Treatment in Acute Ischemic Stroke: Results from the ESCAPE-NA1 TrialJohanna M Ospel, Wu Qiu, Bijoy K Menon, et al.Journal of the American Heart Association|April 16, 2025
Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO-2 TrialAmy Y X Yu, Shabnam Vatanpour, Aravind Ganesh, et al.Journal of Stroke|June 5, 2024
Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized TrialFouzi Bala, Nishita Singh, Katrina Ignacio, et al.International Journal of Stroke : Official Journal of the International Stroke Society|June 7, 2024
Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trialJohanna M Ospel, Dar Dowlatshahi, Andrew Demchuk, et al.Journal of the American Heart Association|June 23, 2026
Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled TrialCorey Adams, Kathy Heard, Yatika Kohli, et al.Pageof 11